Form 4: Nevro Corp. CFO Sells Shares to Cover Tax Obligations

Nevro Corp.'s Chief Financial Officer, Roderick H. MacLeod, sold 816 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Roderick H. MacLeod, the Senior Vice President and Chief Financial Officer of Nevro Corp., sold 816 shares of common stock on November 28, 2024.
• The sale was executed at a price of $4.58 per share.
• This transaction was to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, MacLeod directly owns 133,118 shares of Nevro Corp. common stock, which includes 107,642 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for corporate executives to manage their personal finances and tax obligations related to equity compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 816 shares is relatively small compared to the total holdings of the CFO, which is 133,118 shares.
• Similar transactions are regularly reported by executives at comparable companies in the medical device industry.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale for tax purposes.
• The sale does not indicate any change in the company's financial health or outlook.

Key Dates

Keywords

Nevro Corp, Roderick H. MacLeod, CFO, stock sale, insider trading, Form 4, restricted stock units, tax obligations